Breaking the PMA Bottleneck: How FDA's Class II Reclassification Accelerates Precision Oncology
Dr. Dereck Mush, MD, MBA
Ibex Medical Analytics
Applies artificial intelligence to cancer diagnostics in digital pathology workflows.
What they do
Ibex Medical Analytics provides AI-powered software solutions for pathology laboratories. Its Galen platform analyzes tissue biopsies to assist pathologists in detecting cancer, grading tumor severity, and streamlining diagnostic workflows, thereby reducing errors and turnaround times.
The record
- Vertical
- Oncology
- Sub-segment
- AI-powered pathology diagnostics
- Product type
- Software as a medical device
- Stage
- Series C+
- Headquarters
- Tel Aviv, Israel
- Region
- Middle East & Africa
- Founded
- 2016
- Total funding
- $102M raised
Notable investors: 83North, aMoon Venture Capital, Siena Venture Capital, Octopus Ventures.
Also in Oncology
Related on The Signal
Dr. Dereck Mush, MD, MBA
Digital Pathology Finally Has FDA-Cleared AI. Why Hospital Adoption Is Still Spotty
Dr. Dereck Mush, MD, MBAThe HealthTech Signal
The 8 Best AI Diagnostic Tools of 2026
AI diagnostics stopped being experimental. These eight tools are FDA-cleared, deployed at scale, and quietly changing how disease gets found.
Dr. Dereck Mush, MD, MBA
Beyond PD-L1: How the I3LUNG Consortium Validated Multimodal AI in 2,365 Advanced Lung Cancer Patients
Dr. Dereck Mush, MD, MBA